STOCK TITAN

Inmed Pharmaceuticals Inc (INM) Free Cash Flow by Year

INM

Inmed Pharmaceuticals Inc recorded an outflow of $7.8M in free cash flow in fiscal year 2025. This represents a decrease of 11.0% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Inmed Pharmaceuticals Inc has filed alongside them.

FY2025 annual
Free Cash Flow -$7.8M
YoY -11.0%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INM Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25S-4FY24S-4FY2310-KFY2210-KFY2110-KFY2010-K
Free Cash Flow-$7.8M-11.0%-$7.0M+6.0%-$7.4M+52.4%-$15.6M-59.5%-$9.8M-32.0%-$7.4M

INM Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'26S-4Q2'2610-QQ1'2610-QQ4'25S-4Q3'2510-QQ2'2510-QQ1'2510-QQ4'24S-4Q3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Free Cash FlowN/AN/AN/AN/AN/AN/AN/A-$1.0M-$1.9MN/AN/AN/A

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Inmed Pharmaceuticals Inc financials

Frequently Asked Questions

What was Inmed Pharmaceuticals Inc's free cash flow in fiscal year 2025?

Inmed Pharmaceuticals Inc recorded an outflow of $7.8M in free cash flow in fiscal year 2025.

How fast is Inmed Pharmaceuticals Inc's free cash flow growing?

Inmed Pharmaceuticals Inc (INM) free cash flow fell by 11.0% year over year, from -$7.0M to -$7.8M in fiscal year 2025.

How has Inmed Pharmaceuticals Inc's free cash flow changed over the years?

Across the 6 fiscal years this page covers, Inmed Pharmaceuticals Inc (INM) free cash flow went from -$7.4M in fiscal year 2020 to -$7.8M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Inmed Pharmaceuticals Inc (INM) reported on that line in every period on record.